CVS Health Corp
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -197.1% | – | -37.0% | -124.1% | – | +144.9% | -58.4% | -58.0% | +325.9% | +25.3% | +49.3% | – | |
| – | +0.6% | +0.4% | +1.1% | +0.9% | -1.2% | +0.6% | +1.5% | -298.5% | – | -2.8% | +1.0% | – | |
| – | -17.5% | +7.9% | -2.9% | +0.0% | +3.0% | -8.0% | +7.9% | -192.6% | – | +97.0% | -33.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -94.1% | -1,577.6% | – | – | -121.7% | – | – | – | +109,800.0% | – | |
| – | +67.2% | -22.6% | -9.5% | +5.0% | +14.6% | -3.3% | -18.3% | +15.0% | +12.3% | +8.3% | -18.6% | – | |
| – | -93.7% | +68.6% | -22.4% | +106.0% | -83.7% | +39.3% | +34.4% | +103.8% | -4.3% | -56.3% | +115.6% | – | |
| – | +0.0% | +7.8% | +2.1% | -2.4% | +0.1% | +0.2% | +3.1% | -2.3% | -0.1% | +0.2% | +3.7% | – | |
| – | -66.7% | -302,800.0% | – | -66.7% | -266,300.0% | – | +32.6% | +61.3% | +27.9% | – | – | – | |
| – | – | – | – | – | – | -232.8% | – | -138.1% | +88.8% | +19.8% | +16.5% | – | |
| – | -64.0% | +26.2% | – | -227.1% | – | -641.1% | – | -271.5% | +47.0% | +14.1% | +16.2% | – | |
| – | – | – | +71.5% | -309.4% | – | -16.2% | +14.8% | -259.2% | – | – | +67.3% | – | |
| – | -263.4% | – | -41.6% | -157.7% | – | +249.2% | -66.2% | -92.4% | +2,559.2% | +30.5% | +66.3% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.